Cleared Traditional

K240795 - Withings ECG App (FDA 510(k) Clearance)

Jun 2025
Decision
450d
Days
Class 2
Risk

K240795 is an FDA 510(k) clearance for the Withings ECG App. This device is classified as a Electrocardiograph Software For Over-the-counter Use (Class II - Special Controls, product code QDA).

Submitted by Withings (Issy-Les-Moulineaux, FR). The FDA issued a Cleared decision on June 15, 2025, 450 days after receiving the submission on March 22, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2345. An Electrocardiograph Software Device For Over-the-counter Use Creates, Analyzes, And Displays Electrocardiograph Data, And Can Provide Information For Identifying Cardiac Arrhythmias. This Device Is Not Intended To Provide A Diagnosis..

Submission Details

510(k) Number K240795 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 2024
Decision Date June 15, 2025
Days to Decision 450 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QDA - Electrocardiograph Software For Over-the-counter Use
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2345
Definition An Electrocardiograph Software Device For Over-the-counter Use Creates, Analyzes, And Displays Electrocardiograph Data, And Can Provide Information For Identifying Cardiac Arrhythmias. This Device Is Not Intended To Provide A Diagnosis.